Closed/Expired: Enhancing a novel treatment for RA Patients by Eyeka

Enhancing a novel treatment for RA Patients by Eyeka

Can you convince Rheumatologists that ARTRIBIX should be their go-to RA treatment because it redefines their patients’ experience.

Rheumatoid arthritis (RA) is a chronic inflammatory disorder affecting small joints in the hands and feet. The body’s immune system attacks its own tissue, affecting joint linings, causing painful swelling. This may lead to bone erosion and joint deformity.

Patients who suffer from RA struggle to complete simple tasks such as picking up an object or using a kitchen knife. Pain is also a common symptom; patients have a constant nagging pain when bending or flexing their articulations (hands and knees). Other manifestations include fatigue, depression, osteoporosis, anemia, and cardiovascular disease.

RA patients typically are treated initially with methotrexate which helps up to 35% of patients but they suffer side effects such as fatigue and often need additional pain medication and corticosteroids to manage the pain. But the rest of patients need to move on to more advanced treatment, typically by adding on a biologic treatment (an injection or an infusion). It means they have to go to a doctor to get an infusion, or take an injection regularly. It might have been an advanced therapy 10 years ago, but it’s time for a change!

ARTRIBIX is the first oral (pill) for the advanced treatment of RA working deep inside the cell while the competitors are either injectable or infusion biologic treatments. It has proven single agent efficacy meaning that it can be taken alone, without methotrexate, which redefines patients’ experience because they don’t have to use methotrexate, like they would with biologic treatment. It rapidly relieves important symptoms of RA and has a significant real world experience. If biologic therapy is like a fireman who simply extinguishes the fire, then ARTRIBIX goes into the fire and turns down the gas – which is effective and direct.

Can you help to convince rheumatologist (doctors) that ARTRIBIX is the right choice to liberate their patients from methotrexate and biologic treatment?


Creative Challenge

Through a powerful poster with tagline, convince rheumatologist that prescribing ARTRIBIX instead of methotrexate and biologic treatment can redefine their patients’ experience.


  • #1 Prize €4,000
  • #2 Prize €2,500
  • #3 Prize €2,000
  • #4 Prize €1,000
  • #5 Prize €500

Deadline:- 07-02-2017

Take this challenge